Skip to main content

AVITA Medical, Inc.

RCEL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001762303

In the last 90 days, AVITA Medical, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q2 2026, worth $20.4M in total; no superinvestor holds it.

Other share classesAVHHL

Q3 2021 vs. Q2 2021

How the institutions holding AVITA Medical, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of RCEL: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders71169−1
Shares8.76M3008.34M−417.2K (−4.8%)
Value$179.5M$6.00K$148.0M−$31.5M (−17.5%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held AVITA Medical, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to RCEL in Q3 2021
InstitutionSharesValue% of portfolio
Raymond James & Associates17,124$303.0K0.00%
Millennium Management LLC10,237$181.0K0.00%
ExodusPoint Capital Management, LP10,012$177.0K0.00%
SG Americas Securities, LLC9,308$165.0K0.00%
Lazard Asset Management LLC3,724$65.0K0.00%

Sold out (6)

Institutions that held AVITA Medical, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of RCEL in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Driehaus Capital Management LLC130,000$2.67M
Marshall Wace, LLP30,828$633.0K
Marshall Wace North America L.P.16,212$333.0K
Parametric Portfolio Associates LLC10,621$218.0K
FORA Capital, LLC959$20.0K
Trust Co of Vermont195$4.00K

Not filed for Q3 2021 yet (1)

Institutions that held AVITA Medical, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCEL in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC300$6.00K